Komori
Eiken Chemical (4549) · RiskRestated

Infringement of, and infringement by others of, intellectual property rights

First written in FY2016. 9 of 10 entries say "Restated". Latest entry: FY2019-Q3.

10entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY2019-Q32016: 320162017: 320172018: 320182019: 12019
Same theme, other companies
Third-Party and Own Intellectual Property Rights Infringement RiskA theme 359 companies write about · 360 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2025: 9 of 59 companies on the "Worse" side.

127 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 200 companies compared. The sentences above are computed from all 200.Comparing 200 of the theme's 360 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2019-Q3RestatedAnnual report

    「During the nine-month cumulative consolidated period under review, there were no new business or other risks, and no material changes to the business or other risks described in the securities report for the previous fiscal year.」

    No new risks or material changes relating to infringement of or by intellectual property rights have been identified.
  2. FY2019-Q2RestatedAnnual report

    「During the six-month period ended the second quarter of the current consolidated fiscal year, there were no new business risks or material changes to the business risks described in the previous fiscal year's Annual Securities Report.」

    No new risks or material changes relating to infringement of or by intellectual property rights have been identified.
  3. FY2019-Q1RestatedAnnual report

    「During the first quarter of the current fiscal year, there were no new business or other risks, nor any material changes to the business or other risks described in the securities report for the previous fiscal year.」

    No new risks or material changes relating to infringement of or by intellectual property rights have been identified.
  4. FY2018-Q3RestatedAnnual report

    「During the nine-month cumulative consolidated period under review, there were no new business or other risks, and no material changes to the business or other risks described in the securities report for the previous fiscal year.」

    No new risks or material changes relating to infringement of or by intellectual property rights have been identified.
  5. FY2018-Q2RestatedAnnual report

    「During the six-month period ended the second quarter of the current consolidated fiscal year, there were no new business risks or material changes to the business risks described in the previous fiscal year's Annual Securities Report.」

    No new risks or material changes relating to infringement of or by intellectual property rights have been identified.
  6. FY2017RestatedAnnual report

    「The Group's products are protected for specified periods by patents, utility models and other rights. The Group strictly manages its intellectual property rights, including patent rights and utility model rights, and constantly monitors both the risk of infringement by third parties and the risk that the Group's products may infringe third-party intellectual property rights. However, if the Group's intellectual property rights are infringed by a third party, or if the Group's products infringe third-party intellectual property rights, this could affect the Group's financial position and operating results.」

    The risks of infringement of or by intellectual property rights and the resulting impact on operating results continue to be described.
  7. FY2017-Q3RestatedAnnual report

    「During the nine-month cumulative consolidated period under review, there were no new business or other risks, and no material changes to the business or other risks described in the securities report for the previous fiscal year.」

    No new risks or material changes relating to infringement of or by intellectual property rights have been identified.
  8. FY2017-Q2RestatedAnnual report

    「During the six-month period ended the second quarter of the current consolidated fiscal year, there were no new business risks or material changes to the business risks described in the previous fiscal year's Annual Securities Report.」

    No new risks or material changes relating to infringement of or by intellectual property rights have been identified.
  9. FY2017-Q1RestatedAnnual report

    「During the first quarter of the current fiscal year, there were no new business or other risks, nor any material changes to the business or other risks described in the securities report for the previous fiscal year.」

    No new risks or material changes relating to infringement of or by intellectual property rights have been identified.
  10. FY2016First statedAnnual report

    「The Group strictly manages its intellectual property rights, including patent rights and utility model rights, and constantly monitors both the risk of infringement by third parties and the risk that the Group's products may infringe third-party intellectual property rights.」

    Both infringement of the rights held by the Group and infringement of third-party rights by its products are covered.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Eiken Chemical's next results are scheduled for 2026-10-29. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Infringement of, and infringement by others of, intellectual property rights | EIKEN CHEMICAL CO.,LTD. (4549) | Komori